Sobi's Revenues Decline 3% In Second Quarter, Signs Of Return To Normality In June
Kineret Shows Promise In COVID-19 Related Cytokine Storm Syndrome
Executive Summary
Swedish Orphan Biovitrum’s financial performance in the second quarter was held back by COVID-19 related events, but it has left its financial guidance unchanged for 2020.